98-29612. Oral Dosage Form New Animal Drugs; Sulfadimethoxine Soluble Powder and Oral Solution  

  • [Federal Register Volume 63, Number 214 (Thursday, November 5, 1998)]
    [Rules and Regulations]
    [Pages 59713-59714]
    From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
    [FR Doc No: 98-29612]
    
    
    -----------------------------------------------------------------------
    
    DEPARTMENT OF HEALTH AND HUMAN SERVICES
    
    Food and Drug Administration
    
    21 CFR Part 520
    
    
    Oral Dosage Form New Animal Drugs; Sulfadimethoxine Soluble 
    Powder and Oral Solution
    
    AGENCY: Food and Drug Administration, HHS.
    
    ACTION: Final rule.
    
    -----------------------------------------------------------------------
    
    SUMMARY: The Food and Drug Administration (FDA) is amending the animal 
    drug regulations to reflect approval of two abbreviated new animal drug 
    applications (ANADA's) filed by Med-Pharmex, Inc. One ANADA provides 
    for the use of sulfadimethoxine soluble powder for use in drinking 
    water or as a drench, and the second ANADA provides for the use of the 
    oral solution in drinking water or as a drench, for the treatment of 
    chickens,
    
    [[Page 59714]]
    
    turkeys, and dairy calves, dairy heifers, and beef cattle.
    
    EFFECTIVE DATE: November 5, 1998.
    
    FOR FURTHER INFORMATION CONTACT: Lonnie W. Luther, Center for 
    Veterinary Medicine (HFV-102), Food and Drug Administration, 7500 
    Standish Pl., Rockville, MD 20855, 301-827-0209.
    
    SUPPLEMENTARY INFORMATION: Med-Pharmex, Inc., 2727 Thompson Creek Rd, 
    Pomona, CA 91767-1861, has filed both ANADA 200-238 that provides for 
    the use of Sulfasol (sulfadimethoxine) soluble powder, and 
    ANADA 200-251 that provides for use of Sulforal 
    (sulfadimethoxine) concentrated solution, both for use in drinking 
    water or as a drench for the treatment of disease outbreaks as follows: 
    Coccidiosis, fowl cholera, and infectious coryza in chickens; 
    coccidiosis and fowl cholera in meat-producing turkeys; and shipping 
    fever complex and bacterial pneumonia associated with Pasteurella spp. 
    sensitive to sulfadimethoxine, and calf diphtheria and foot rot 
    associated with Sphaerophorus necrophorus sensitive to sulfadimethoxine 
    in dairy calves, dairy heifers, and beef cattle.
        ANADA 200-238 is approved as a generic copy of Pfizer, Inc.'s NADA 
    46-285 for Albon (sulfadimethoxine soluble powder). ANADA 
    200-238 is approved as of July 28, 1998.
        ANADA 200-251 is approved as a generic copy of Pfizer, Inc.'s NADA 
    31-205 for Albon (sulfadimethoxine 12.5% concentrated 
    solution). ANADA 200-251 is approved as of August 3, 1998.
         Currently the regulations in Sec. 520.2220a (21 CFR 520.2220a) do 
    not specify which sponsors have approval for the oral solution or the 
    soluble powder. The section is amended to combine paragraphs (a) and 
    (b) to specify the approvals, including the new approvals. The basis 
    for approval is discussed in the freedom of information summaries.
         In amending Sec. 520.2220a paragraph (a) is revised, paragraph (b) 
    is removed, and paragraphs (c) through (e) are redesignated as 
    paragraphs (b) through (d), respectively.
        In accordance with the freedom of information provisions of 21 CFR 
    part 20 and 514.11(e)(2)(ii), a summary of safety and effectiveness 
    data and information submitted to support approval of these 
    applications may be seen in the Dockets Management Branch (HFA-305), 
    Food and Drug Administration, 5630 Fishers Lane, rm. 1061, Rockville, 
    MD 20852, between 9 a.m. and 4 p.m., Monday through Friday.
        The agency has determined under 21 CFR 25.33(a)(1) that this action 
    is of a type that does not individually or cumulatively have a 
    significant effect on the human environment. Therefore, neither an 
    environmental assessment nor an environmental impact statement is 
    required.
    
    List of Subjects in 21 CFR Part 520
    
        Animal drugs.
        Therefore, under the Federal Food, Drug, and Cosmetic Act and under 
    authority delegated to the Commissioner of Food and Drugs and 
    redelegated to the Center for Veterinary Medicine, 21 CFR part 520 is 
    amended as follows:
    
    PART 520--ORAL DOSAGE FORM NEW ANIMAL DRUGS
    
        1. The authority citation for 21 CFR part 520 continues to read as 
    follows:
    
        Authority: 21 U.S.C. 360b.
        2. Section 520.2220a is amended by revising paragraph (a), by 
    removing paragraph (b), and by redesignating paragraphs (c) through (e) 
    as paragraphs (b) through (d), respectively, to read as follows:
    
    
    Sec. 520.2220a  Sulfadimethoxine oral solution and soluble powder.
    
        (a) Approvals. (1) For oral solution containing 12.5 percent (3.75 
    grams per ounce) sulfadimethoxine, see Nos. 000010, 000069, 051259, 
    057561, and 059130 in Sec. 510.600(c).
        (2) For soluble powder, each package containing the equivalent of 
    94.6 grams of sulfadimethoxine (as the sodium salt), see Nos. 000069, 
    051259, and 057561 in Sec. 510.600(c).
    * * * * *
    
        Dated: October 22, 1998.
     Stephen F. Sundlof,
     Director, Center for Veterinary Medicine.
    [FR Doc. 98-29612 Filed 11-4-98; 8:45 am]
    BILLING CODE 4160-01-F
    
    
    

Document Information

Effective Date:
11/5/1998
Published:
11/05/1998
Department:
Food and Drug Administration
Entry Type:
Rule
Action:
Final rule.
Document Number:
98-29612
Dates:
November 5, 1998.
Pages:
59713-59714 (2 pages)
PDF File:
98-29612.pdf
CFR: (1)
21 CFR 520.2220a